1. |
[1]WHO.World health report 1999[R].Geneva WHO,1999.
|
2. |
[2]European stroke initiave. Recommendation for stroke management[J]. Cerebrovascular Diseases 2000;10:335-351.
|
3. |
[3]王家良.臨床流行病學-臨床科研設計,衡量與評價[M]第2版上海:上海科學技術出版社,2001:47-72.
|
4. |
[4]The standards of reporting trials group. A proposal for structured reporting of randomized controlled trials[J].JAMA 1994;272:1926-1931.
|
5. |
[5]Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials[J].JAMA 1996;276:637-639.
|
6. |
[6]Schulz KF, Chalmers I, Hayes R J, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials[J]. JAMA 1995;273:408-412.
|
7. |
[7]Duncan PW, Jorgensen HS, Wade DT. Outcome measures in acute stroke trial [J].Stroke 2000;31:1429-1438.
|
8. |
[8]劉鳴,張世洪新知識:臨床試驗中的意向處理分析[J].英國醫學雜志中文版2001;4:223-224.
|